USR Tarragona-Reus

RESPONSABLE
avatar_investigadors.jpg
Enric Aragonès Benaiges
earagones.tgn.ics@gencat.cat
Reus-Tgn - USR equip

Publications

How valid are the codes used to identify acute liver injury (ALI)? A study in 3 European data sources

J. FORNS, M. CAINZOS-ACHIRICA, M. HELLFRITZSCH, M. GINER-SORIANO, B. POBLADOR-PLOU, J. HALLAS, R. MORROS, A. PRADOS-TORRES, A. POTTEGARD, J. CORTES, J. AGUADO, J. CASTELLSAGUE, E. JACQUOT, N. DELTOUR, S. PEREZ-GUTTHANN and M. PLADEVALL
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018 Aug 1;

  • Year: 01/08/2018
  • FI: 2.87
  • Article

Primary care recorded NAFLD and the risk of incident MI and stroke: Findings from analyses of 18 million patients in the UK, the Netherlands, Spain, and Italy

M. ALEXANDER, K. LOOMIS, J. VAN DER LEI, T. DUARTE-SALLES, D. PRIETO-ALHAMBRA, D. ANSELL, A. PASQUA, F. LAPI, P. RIJNBEEK, M. MOSSEVELD, P. AVILLACH, P. EGGER, N. DHALWANI, S. KENDRICK, D. WATERWORTH, W. ALAZAWI and N. SATTAR
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018 Aug 1;

  • Year: 01/08/2018
  • FI: 2.87
  • Article

Estimating incidence of adverse events following vaccination in observational databases when exposure information is unavailable: A contribution from the advance project

C. DODD, K. BOLLAERTS, M. DE RIDDER, O. MAHAUX, F. HAGUINET, T. DE SMEDT, A. CORREA, T. DUARTE-SALLES, H. EMBORG, C. HUERTA, E. MARTIN, G. PICELLI, K. BERENCSI, G. DANIELI, M. STURKENBOOM and D. WEIBEL
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018 Aug 1;

  • Year: 01/08/2018
  • FI: 2.87
  • Article

Agomelatine and other antidepressants and the risk of acute liver injury (ALI), a pass in four European countries

M. PLADEVALL, J. HALLAS, T. SCHINK, J. REUTFORS, R. MORROS, B. POBLADOR-PLOU, J. FORNS, M. HELLFRITZSCH, T. REINDERS, D. HAGG, M. GINER-SORIANO, A. PRADOS-TORRES, M. CAINZOS-ACHIRICA, A. POTTEGARD, B. KOLLHORST, L. BRANDT, J. CORTES, J. AGUADO, G. PERLEMUTER, J. CASTELLSAGUE, E. JACQUOT, N. DELTOUR and S. PEREZ-GUTTHANN
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018 Aug 1;

  • Year: 01/08/2018
  • FI: 2.87
  • Article

Advance system testing: Benefit-risk analysis of a marketed vaccine using cohort modelling and MCDA swing weighting

K. BOLLAERTS, E. LEDENT, T. DE SMEDT, D. WEIBEL, H. EMBORG, K. BERENSCI, A. CORREA, G. DANIELI, T. DUARTE-SALLES, C. HUERTA, E. MARTIN, G. PICELLI, L. TRAM, L. TITIEVSKY, M. STURKENBOOM and V. BAUCHAU
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018 Aug 1;

  • Year: 01/08/2018
  • FI: 2.87
  • Article

Board of Trustees

Collaborators

Accreditations